ÂÜÀòÂÒÂ×

The Scientific Team at Adverum Biotechnologies conducts cutting-edge research and development to advance gene therapy treatments for ocular and rare diseases. They design, evaluate, and optimize therapeutic candidates like ADVM-022 through rigorous scientific analysis and clinical studies. The team also collaborates with medical and technological experts to ensure the efficacy and safety of innovative treatments for conditions such as wet age-related macular degeneration.